0001019056-18-000956.txt : 20180813
0001019056-18-000956.hdr.sgml : 20180813
20180813164548
ACCESSION NUMBER: 0001019056-18-000956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180809
FILED AS OF DATE: 20180813
DATE AS OF CHANGE: 20180813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mitchell Shawnte
CENTRAL INDEX KEY: 0001749432
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 181012821
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
ownership.xml
X0306
4
2018-08-09
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001749432
Mitchell Shawnte
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
0
1
0
0
SVP, GC and Corporate Affairs
Common Stock
2018-08-09
4
M
0
1630
A
76135
D
Common Stock
2018-08-09
4
F
0
383
4.50
D
75752
D
Restricted Stock Units
2018-08-09
4
M
0
1630
0
D
Common Stock
1630
6787
D
Restricted stock units convert into shares of the Issuer's common stock on a one-for-one basis.
On August 10, 2015, the reporting person was granted 4,892 restricted stock units. 1,631 shares of common stock underlying the restricted stock units vested on each of August 9, 2016 and August 9, 2017, and 1,630 vested on August 9, 2018.
/s/ Carl A. Valenstein, attorney-in-fact
2018-08-13